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Mouse Th cells arecharacterizedby a distinct pattern ofsurfacemarkers, including
Thy-1, Lyt-1 (CD5), and L3T4 (CD4), but not Lyt-2 (CD8), antigens (1). These
cells recognize class II MHC alloantigens and heterologous protein antigens in as-
sociation with autologous class II MHC molecules on APC (2, 3). Although Th
cellscannot be furthersubdivided phenotypicallyinthemouseusingcurrentlyavailable
subset-specific antibodies, they have shown a clear functional heterogeneity (4-11).
Based on the analysis ofa large group of mouse Th cell clones, at least two types
ofmouse Th clones have beenidentified thatdiffer in function, and in their patterns
ofcytokine secretion (12, 13). Thl clones synthesize IL-2, IFN-'Y, andlymphotoxin,
and mediate delayed-type hypersensitivity (DTH)t reactions in adoptive hosts (14,
15). Thl clones can be cytotoxic for class II MHC-bearing target cells pulsed with
specific antigens (16), and can suppress an in vitro IgE response, due to secretion
ofIFN-,y (17-19). Th2 clones secreteIL-4, IL-5, and IL-6, and augmentB cellprolifer-
ation and antibody production (20-26). They are effective in T cell-dependent hu-
moral immuneresponses, especially forhelping IgE production, which is mediated
by IL-4. Both types of Th clones synthesize GM-CSF, TNF, IL-3, and prepro-
enkephalin (27). They also exhibit similar growth properties in vitro (27).
The goalofthe present studywas to compare the cell-mediated and humoral im-
mune responses ofCD4' spleen cells oftotal lymphoid irradiation (TLI)-treated
and normal BALB/c mice. TLI consists offractionated irradiation delivered selec-
tively tothe majorlymphoid tissues, includingthespleen,thymus, andlymphnodes
(28). Changes in the function ofpurified peripheral blood CD4' (Leis-3 +) lympho-
cytes in humans given TLI have been reported previously (29-31). In particular,
thesecells show areduction in the proliferative responses to mitogens, alloantigens,
and heterologous proteins in vitro as compared with CD4' cells from normal indi-
viduals. Similarly, CD4' spleen cells from TLI-treated mice showed a marked
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deficit in the MLR that was associatedwith reduced IL-2 secretion and normal IL-
2-R expression (Bass, H., and S. Strober, manuscript submitted for publication).
The results of the present study using TLI-treated BALB/c mice indicate that
there are two or more functionally distinct mouse CD4 subsets in vivo. One subset
of cells (Thl-like) secretes IL-2 and/or IFN-y and contributes to cell-mediated im-
munity. The function of these cells recovers slowly after TLI (at -3 mo) to the
pretreatment levels. Another subset ofcells (Th2-like) secretes IL-4 and/or IL-5 and
plays a critical role in humoral immunity. The latter cells return more rapidly (at
N4-6 wk) after the irradiation. This results in a transient change in the proportion
of these two subsets in the spleens of TLI-treated mice, such that Thl-like cells are
selectively reduced after irradiation.
Materials and Methods
Animals.
￿
BALB/c (H-2d), C57BL/Ka (H-2 b), and C3H/Km (H-2k) mice were obtained
from the specific pathogen-free colony in the Department of Radiology, Stanford University
Medical School. During administration of irradiation, BALB/c mice were housed in conven-
tional animal rooms. Tetracycline (0.5 jig/ml) was added to the drinking water during the
3 wk of TLI treatment. CBA/J (H-2Ik) mice were purchased from TheJackson Laboratory
(Bar Harbor, ME) and were housed in the Stanford Medical Center animal facility.
TLI.
￿
4-6-mo-old male BALB/c mice were placed in an apparatus designed to irradiate
the major lymphoid organs, including all major lymph nodes, spleen, and thymus, as previ-
ously described (18). The mice were given 250 rad/d, five times per week, for a total dose
of4,250 rad in 17 treatments. TLI was delivered from a single 250-Kv (15 A) source (Phillips
Medical System Inc., Shelton, CT).
Whole Body Irradiation (WBI).
￿
The mice were placed in lucite containers and given a
sublethal dose of 550 rad, or a lethal dose of 850-rad irradiation. WBI was delivered from
a single 250-Kv (15 A) source (Phillips Medical System Inc.). The dose rate was 93 rad/min,
using a 0.35-mm Cu filter at a 52-cm source-axis distance.
Preparation ofCells.
￿
Spleens were removed aseptically and a single cell suspensionwas pre-
pared by gently pressing the spleen through a nylon fibermesh (Tetko Inc., Elmsford, NY).
Immunofluorescent Staining andAnalysis Using the FACS .
￿
The rat anti-mouse mAbs used for
immunofluorescent staining included antiThy-1.2 (clone 30-H12, IgG2a; American Type Cul-
ture Collection [ATCC], Rockville, MD), anti-IgM (11B5, IgGI ; gift of Dr. I. Weissman,
Stanford University), anti-CD8 (Lyt-2 in mouse, clone 53-6.76, IgG2a; ATCC), anti-CD4
(L3T4 in mouse, GK 1.5, IgG2b; Becton Dickinson & Co., Mountain View, CA). Hamster
anti-mouse IL-2-R mAb (M7/20) (IgM), was obtained from Dr. V. Kelley, Harvard Univer-
sity, Cambridge, MA. Fluoresceinated goat anti-rat Ig used as the second-stage antibody
was purchased from Boehringer Mannheim Biochemicals (Indianapolis, IN). Phycoerythrin-
conjugatedanti-CD8 and CD4 antibodies were also obtained from Becton Dickinson & Co.
A rat anti-mouse idiotype mAb was used as an irrelevantcontrol for staining with rat-derived
antibodies (Dr. R. Levy, Stanford University). The concentration of the staining reagents
corresponded to their saturation points on the standard dilution curves.
Immunofluorescent staining procedures were as described previously (29). The stained
cells were analyzed on a FACS II (Becton Dickinson & Co.). The negative controls contained
cells stained with an irrelevantfirst-stage antibody. The percentage of positive cells was deter-
mined by thresholdsdescribed previously (29). Approximately 2-3% ofthe cells stained with
irrelevant antibody were positive at this threshold point.
Purification of Ig* Cells.
￿
A technique similar to that of Wysocki and Sato (32) was used.
Petri dishes were coated with affinity-purified goat anti-rat IgG (Boehringer Mannheim Bio-
chemicals) at 4°C for 10-12 h. Ammonium chloride potassium-treated spleen cells were first
incubated on ice with rat anti-mouse Thy-1.2 mAb (clone 30-H12; Becton Dickinson & Co.)
for 30 min. The cells were then washed and added to the coated petri dishes. 1 h later, the
nonadherent cells were collected, washed, and resuspended in PBS.BASS ET AL.
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After each panning procedure, the negatively selected cells were stained with rat antiThy-
1.2 mAb (see above) or monoclonal rat anti-IgM (11B5), and analyzed on a FACS in order
to check the purity of the cells. The Ig' cells were enriched from a mean of 45 .2% of the
totalspleen cells to a mean of81.8% ofthe transferred "panned" cells. The mean contamina-
tion of the Thy-1.2' cells after panning for B cells was 2.2%.
Purification of CD4' Cells.
￿
To purify CD4' cells, petri dishes were coated with affinity-
purified goat anti-mouse IgG' IgM (Tago Inc., Burlingame, CA) at 4°C for 10-12 h. After
incubation at room temperature for 1 h, the nonadherent cells were collected, washed, and
incubated on ice with rat anti-mouse CD8 mAb (clone 53-6.7; ATCC), for 30 min. The
cells were then washed and added to affinity-purified goat anti-rat IgG (Boehringer Mann-
heim Biochemicals)-coatedpetridishes. 1 h later, the nonadherent cells were collected, washed,
and resuspended in PBS.
After each panning procedure, the purified CD4' cells were stained with mAbs and ana-
lyzed using the FACS II in order to checkthe purity of the cells. After the panning procedure,
the CD4' cells were enriched from a mean of 24.3% of the unfractionated spleen cells to
a mean of 80.4% of the purified (panned) cells. The mean contamination of Ig' and CD8'
cells was 5.3% and 3.2%, respectively.
DTH.
￿
24 h after sublethal whole body irradiation (550 rad), BALB/c mice were injected
intravenously with syngeneic spleen cells and intraperitoneally with TNP keyhole limpet
hemocyanin (TNP-KLH; 100 ug/mouse). KLH (purchasedfrom Calbiochem-Behring Corp.,
LaJolla, CA) was conjugated with TNP according to the method of Little and Eisen (33).
3 wk later, the immunized mice were injected subcutaneously in the left footpad with 30 pl
of TNP-KLH (15 pg/mouse) in PBS and in the right footpad with the same volume of PBS.
Footpad thickness was measured both before and at different time points after the injection
by using a dial-gauge caliper (7312; Mitutoyo). Footpad swelling is signified in the graph as
the difference between the thickness of the experimental (TNP-KLH injected) and control
(PBS injected) foot of each mouse. Data are presented in 10-3 cm.
Adoptive Cell Transfer Procedure.
￿
Adoptive hosts were given a single dose of whole body
sublethal irradiation (550 rad). 24 later, graded numbers ofnonfractionated syngeneic spleen
cells or CD4' cells plus IgG' cells from normal or TLI-treated mice were injected into the
hosts' tail vein. At the same time, the mice were immunized intraperitoneally with TNP-
KLH . Each injection contained 100 hg TNP-KLH diluted with PBS in a total volume of
250 p,l. The mice were bled from the retro-orbital veins both before immunization and at
weekly intervals after immunization. The blood was allowed to clot at room temperature.
Serum was separated by centrifugation and stored at -20°C for further testing.
Antibody Determination.
￿
Serum antibody to TNP was measured by the indirect ELISA as
described previously (34). Flat-bottomed microtiter plates (96-well; Dynatech Laboratories,
Inc., Alexandria, VA) were coated with TNP-BSA. Serial two-fold dilutions ofthe serum samples
were added for 1 h at room temperature. The plates were washed and incubated at room
temperature with 100 pl ofa 1 :3,000 dilution ofperoxidase-conjugated goat anti-mouse IgG
(y and L chain specific, Tago Inc.). 1 h later, the plates were washed and 100,ul/well of sub-
strate solution containing 15 pg/ml of2,2,azino-Di-(3-ethylbenzthiazoline) sulfonic acid (Sigma
Chemical Co., St. Louis, MO) and 0.3 % H202 in citrate buffer (pH 4) were added. Anti-
body responses are represented in units, whereby, the number of units = (1/dilution of ex-
perimental serum [at a given OD])/(1/dilution of standard serum).
IgE-speck ELISA.
￿
The same reagents and techniques described by Coffman and Carty
(18) were used. Briefly, polyvinyl chloride 96-well plates (Dynatech Laboratories, Inc.) were
coated for 2 h with an anti-IgE mAb, EM 95, at a concentration of 4.0 Jig/ml. The nonspecific
binding sites were blocked with PBS plus 20% FCS. The plates were washed with PBS plus
0.04% Tween 20. The standard sample and experimental serum were added to wells at graded
concentrations in 100 pl. Then the plates were incubated overnight at 4°C. The plates were
then washed again with PBS plus 0.04% Tween 20. The second-step antibody, nitroiodophenyl
acetic acid-conjugated purified anti TNP-KLH, was added and incubated at room tempera-
ture for 4 h. An optimum concentration (1 :3,000) of horseradish peroxidase-conjugated anti-
NIP mAb was added afterthe plates were washed yet again. 1 h later, the plates were washed1498
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and 100 Al/well substrate solution was added. The plates were read on an ELISA machine
(Dynatech Laboratories, Inc.).
Graft vs. Host Disease (GVHD) Assay.
￿
24 h after C57BL/Ka (H-2b) mice were lethally ir-
radiated with a single dose of 850 rad, the recipients were injected intravenously with 2.5 x
106 allogeneic bone marrow (BM) cells obtained from the femurs and tibias of BALB/c (H-2d)
mice. Graded numbers of purified spleen CD4* cells from either normal or TLI-treated
BALB/c mice were injected intravenously together with BM cells. The control groups in-
cluded lethally irradiated mice given no cells and mice injected with allogeneic BM cells alone.
The mortality rate in all groups was recorded up to 100 d after cell transfer.
GVHD Suppression Assay.
￿
The experimental conditions were the same as those described
above for the GVHD assay except that 2.5 x 106 putative suppressor cells (TLI CD4* cells)
were coinjected into one group of the recipients with an equal number of normal CD4* cells
and allogeneic BM cells. Mice that received CD4* and BM cells from either normal or TLI
donors were part of the control groups. The mortality rate was recorded up to 100 d after
cell transfer.
Establishment ofAlloreactive Clones.
￿
Cells specific for alloantigens were cloned directly from
the spleens ofnormal or TLI-treated BALB/c mice by limiting dilution with irradiated CBA/J
stimulator cells (2 x 105/well) (U-bottomed 96-well plate; Costar, Cambridge, MA) using
the technique described previously by Mosmann et al. (12). The clones were grown on alter-
nate cycles ofalloantigen stimulation once every 2 wk, alternating with growth in the medium
alone, which includes RMPI 1640, 10% FCS, 0.05 mM 2-ME, 50 Rg/ml gentamicin, and
mouse rIL-2 (400-500 U/ml). Depending upon the density of cell growth in the wells, the
cultured cells were expanded to another 96-well plate using the same medium.
Stimulation of CD4* Clones and Spleen Cellsfor Cytokine Secretion.
￿
Alloreactive clones were
washed twice and resuspended in IL-2-free medium containing 5 Fig/ml Con A, (Calbiochem-
Behring Corp.). The supernatants were harvested 24 h laterand analyzed using specific bio-
assays for the presence of IL-2 and IL-4 and in two-site sandwich ELISAs for the presence
of IFN--y and IL-5. Spleen cells from normal or TLI-treated BALB/c mice (107/ml) were
washed and resuspended in RPMI 1640 containing 10% FCS. These cells were stimulated
with hamster anti-mouse T3 antibody (gift ofDr. J. Bluestone, University ofChicago) diluted
to 1 :200, or Con A (5 kg/ml) plus PMA (10 ng/ml). The stimulation supernatants were har-
vested 8 and 24 h later and assayed for cytokine secretion.
Cytokine Determinations of IL-2 and IL-4.
￿
Samples were assayed for IL-2 and IL-4 using
the colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) (M2128;
Sigma Chemical Co.) proliferation assays as described previously (35). Briefly, IL-2 was as-
sayed on HT-2 cells in the presence of 11b11 anti-IL-4 mAb, and IL-4 was assayed on HT-2
cells in the presence of S4B6 anti-IL-2 mAb. Additional controls included testing samples
on HT-2 cells alone or in the presence of both anti-IL-2 and anti-IL-4 antibodies. 1 U is
defined as the amount of factor in 100 Al that resulted in a signal in the MTT assay equal
to 50% of maximum signal.
CytokineDeterminations ofIFN-y andIL-5.
￿
Samples were assayed for IFN-'f and IL-5 using
two-site sandwich ELISAs (13, 36). Briefly, microtiter plates were coated with either mAb
XMG 1.2 in PBS for IFN--y or mAb TRFK5 in PBS for IL-5. After incubation with test
samples and murine rIFN-.y and IL-5 standards, the plates were washed and incubated with
affinity-purified rabbit anti-mouse IFN-y for assaying IFN-'y or biotin-conjugated mAb
TRFK2 for assaying IL-5. The plates were then washed and incubated with goat anti-rabbit/
horseradish peroxidase conjugate (The Jackson Laboratory) for testing IFN-'y, and strept-
avidin-conjugated horseradish peroxidase for testing IL-5. Cleavage ofthe substrate 2,2'-azino-
Di (3-ethylbenzthiazoline sulfonic acid) (ABTS) was determined on a VMAX microplate
reader (Molecular Services, Menlo Park, CA).
Phenotyping ofAlloreactive Clones.
￿
The surface antigen phenotype of the clones was deter-
mined by a cytotoxicity assay using anti-CD8 or anti-CD4 mAbs (Cedarlane Laboratories,
Homby, Ontario, Canada) and complement (C'). Cytotoxicity was evaluated using the colori-
metric MIT assay (35). The percentage ofkillingwas calculated as: 100 x [control wells(C'+
medium) - assay wells (C' + antibodies)]/control wells.
Statistical Analysis.
￿
Statistical analyses were performed by using student's t test (two tailed).Results
Comparison ofAdoptive TransferofSpleen Cellsfrom Normal and TLI-treatedMice: Anti-
body Production andDTHResponsein theSame Recipients. 24 hafterbeing given a single
dose of whole body irradiation (550 rad), BALE/c mice were given TNP-KLH in-
traperitoneally and graded doses of syngeneic unfractionated spleen cells intrave-
nously from normal or TLI-treatedmice. In all instances, spleen cells were obtained
from TLI-treatedmice 4-6 wk aftercompletion ofirradiation. Previous experiments
have shown that the percentage of CD4+ cells in the spleen was approximately
normal at this time point afterTLI (Bass, H., and S. Strober, manuscript submitted
forpublication). Serumwas obtained before andat weekly intervalsaftercell transfer
and immunization. 21 d after the primary immunization, host footpads were in-
jected subcutaneously with TNP-KLH. Footpad swelling was measured before and
at different time points after the local immunization. This experimental system as-
sayed both the DTH reaction and antibody production in the same mouse.
Fig. 1 shows the results of DTH footpad swelling. As expected, in mice receiving
normal spleen cells, theswelling peaked at 24 h afterlocalimmunization and started
to decrease after 30 h. The control mice that received no cells but had antigen in-
jected into theirfootpads showed no specific swelling. Thefootpad swelling increased
with increasing numbers of cells transferred (6.25 x 106 to 101 cells) from normal
mice. When 5 x 101 cells were transferred from TLI-treated mice, the response was
less than that with 6.25 x 106 normal cells. Thus, the TLI cells were at least eight
timesless efficientthan normal cellsin causing footpad swelling in aDTHreaction.
This pattern was observed in two similar experiments.
Fig. 2 shows the serum antiTNP antibody response in the same groups of mice.
The response peaked at days 14-21 after immunization. Background levels of anti-
body were seen in the control mice that did not receive cells. Again, the production
of antiTNP antibody increased substantially in the groups of mice receiving be-
tween 6.25 x 106 and 101 normal spleen cells. However, it was found that the anti-
TNP antibody response transferred by 5 x 10' TLI spleen cells was similar to that
with the same dose of normal spleen cells. The difference between these two groups
was not statistically significant (p 3 0.05). This pattern was observed in three other
similar experiments.
z
J ^
J
Wo 3 0
N X
O U
Q ` .
F
o °
a
ISO
120
so
e0
0
BASS ET AL.
￿
1499
FIGURE 1.
￿
Comparison of DTH after adoptive
transfer ofnormal andTLIspleen cells. 24 hafter
whole body sublethal irradiation (550 rad),
BALB/c mice were injected intravenously with
graded numbersof syngeneic spleen cells andin-
traperitoneally with TNP-KLH (100 pg/mouse).
3 wk later, the immunized mice were injected sub-
cutaneously in the footpad with TNP-KLH (15
kg/mouse). Thesymbols in the graph represent
no cells (O); 6.25 x 106 normal spleen cells (N);
1.25 x 107 normal spleen cells (A); 2.5 x 107
normal spleen cells (A); 5 x 107 normal spleen
cells (0); 108 normal spleen cells (* ); and 5 x
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FIGURE 2.
￿
Comparison ofantibodyproduction
after adoptive transfer ofnormal and TLI spleen
cells. 24 h after sublethal irradiation (550 rad),
BALB/c mice were immunized intraperitoneally
with TNP-KLH (100 ug/ml). Simultaneously,
nonfractionated syngeneic spleen cells from
normal or TLI mice were injected into the host
tail veins. The mice were bledfrom retro-orbital
veins before and at weekly intervals after immu-
nization. The serum antiTNP antibody concen-
tration was measured by indirect ELISA. The
symbols inthe graph represents no cells(0); 6.25
x 106 normal spleen cells (N); 1.25 x 107
normal spleen cells (A); 2.5 x 107 normal spleen
cells (A); 5 x 107 normal spleen cells (0); 108
normal spleen cells (*); and 5 x 107 TLI spleen
cells (0). There were six mice in each group.
Augmentation ofAntibody Production by Normal Ig' Cells UsingNormal and TLISplenic
CD4' Cells. To study the ability ofTLI CD4+ cells to assist normal Ig' cells in
secreting antibodies, Ig' cells (5 x 106) and graded numbers of CD4+ cells were
injected together into sublethally irradiated syngeneic BALB/c mice. Each mouse
also received TNP-KLH antigen intraperitoneally. The serum antiTNP antibody
concentration inELISA units is shown in Fig. 3. Thepeak ofthe antibody response
was on days 14-21. The negative control group, irradiated mice without transferred
cells, showed background levels of specific antibody. The mice that received either
only Ig' cells or CD4+ cells showed low background antibody responses. Increasing
doses of TLI or normal CD4+ cells (5 x 105 to 5 x 106) with a constant number
ofIg' cells produced increasing antibody responses. Although the TLI CD4+ cells
at day 7 produced lower levels of antibody than the normal control CD4+ cells, the
two groups showed no significant differences 14 and 21 d after cell transfer and im-
munization (p > 0.05). A similar pattern was observed in two other experiments.
Augmentation ofAntigen-specific IgE Production by Normal Ig' Cells Using Normal and
TLI Splenic CD4+ Cells. It has been shown in other studies that IFN-'Y and IL-4
regulate IgE antibody synthesis reciprocally; while IL-4 enhances IgE production
>100 times in LPS-stimulated B cell cultures, a small amount ofIFN--y can com-
pletely inhibit such a response (18, 19). The difference in IgE production is one of
the most important functionaldifferences between Thl andTh2 clones. Therefore,
it was essential to determine the antigen-specific IgE levels in the serum samples
collected from the mice receiving adoptive cell transfer as shown above. As shown
in Table I, the pre-bleed group and the mice receiving only antigen, Ig' cells, or
CD4' cells alone had minimal amounts of IgE antibody. The results also showed
a clear dose-response curve when graded numbers of CD4' cells were added with
a constant number of Ig' cells. The IgE antibody level in mice given CD4' and
Ig' cells was higher on day 7 than day 14 or 21. CD4' cells from TLI mice were
capable of helping normal Ig' cells to produce higher levels of specific IgE anti-
bodies than the same number of CD4' cells from BALB/c control mice. The av-
erage percentage increase on day 7 in the IgE level using TLI vs. normal CD4'
cells was 98% in the group given 5 x 105, 101% in the group given 2 x 106, and
62% in the group given 5 x 106 CD4' cells. These increases were significantly
different for all groups (p 4 0.01).Z
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TABLE I
Comparison of the Adoptive IgE Response Using CD4' Cells from Normal or TLI-treated Mice
1501
FIGURE 3.
￿
Comparison of antibody response
transferred by normal Ig' cells and CD4' cells
from eithernormalorTLI-treated mice. 24 hafter
sublethal irradiation, BALB/c mice were im-
munized intraperitoneally with 100 hg TNP-
KLH (N). Simultaneously, each mouse was in-
jected intravenously with 5 x 106 syngeneic Ig'
spleen cells (p); 5 x 106 syngeneic CD4' cells
(A); or the combination ofIg' cells with graded
numbers ofCD4' spleen cells; 5 x 105 (A); 2 x
106 (O); and 5 x 106 ("). The mice were bled
from retro-orbital veins before andat weekly in-
tervals afterimmunization. Theserum antiTNP
antibody concentration wasmeasuredby indirect
ELISA. There were four mice in each group.
Sublethally irradiated BALB/c mice were immunized intraperitoneally with TNP-KLH (100 1&g/mouse). The
mice were also injected intravenously with syngeneic Ig' cells and/or CD4' cells from either normal or TLI-
treated mice. Theserum IgEanti-TNP-KLH antibody concentration wasmeasured by indirect ELISA. Values
shown are in units calculated as: [I/dilution of experimental serum (at agiven OD)]/(I /dilution of standard
serum). See Materials and Methods for details.
Antigen Ig' Cells CD4' cells Day 0 Day 7 Day 14 Day 21
+ - - <1 13.3 t 0.8 9.8 t 0.5 17.9 t 2.5
+ 5 x 106 - <1 15.6 t 2.8 13 .5 t 0.4 25.3 t 2 .4
+ - Normal 5 x 106 <1 20.6 t 2 .6 11 .6 t 0.9 14.1 t 0.9
+ 5 x 106 Normal 5 x 10' <1 144.0 t 5.5 155 .0 t 24.7 70.3 t 8.8
+ 5 x 106 Normal 2 x 106 <1 85.3 t 11 .4 176.0 t 19.6 115.0 t 59 .5
+ 5 x 106 Normal 5 x 106 <1 302.0 t 18.2 214.0 t 32.6 186.0 t 13 .0
+ - TLI 5 x 106 <1 64.8 t 7.1 9.9 t 0.8 25.0 t 1 .2
+ 5 x 106 TLI 5 x 101 <1 263.8 t 27.3 156.0 t 16.6 218.0 t 21 .4
+ 5 x 106 TLI 2 x 106 <1 378.0 t 41 .1 332.0 t 27.7 244.0 t 57.0
+ 5 x 106 TLI 5 x 106 <1 489.0 t 42.3 375.0 t 75.0 279 .0 t 29.71502
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Comparison ofGVHD Mediated by Normal and TLI CD4+ Cells.
￿
24 h after lethal
whole body irradiation, C57BL/Ka (H-2b) mice received an intravenous injection
of2.5 x 106 normal BALB/c (H-2d) BM cells and purified CD4' cells from either
normal or TLI-treated mice. The clinical signs ofGVHD and mortality rate ofall
groups were recorded up to 100d after the cell transfer. Fig. 4 shows that there was
aclose correlation between the dose oftransferred CD4' cells and the survival rate
inboth groups ofmice. All six C57BL/Kamice given allogeneic bone marrow alone
survived >100 d. None of the irradiated mice without bone marrow cell transfer
lived >14 d. When 2.5 x 106 normal CD4' cells were injected, five ofsix mice died
by 100 d after cell transfer. The same dose ofTLI CD4' cells only resulted in one
death within six mice. Similarly, 5 x 106 TLI CD4' cells caused a higher mortality
rate (two of the six mice died) than 5 x 105 normal CD4' cells (one of six mice
died) but a lower mortality rate than 106 normal CD4' cells (three ofsix mice died).
From these results, the TLI CD4' cells were estimated to be about seven to eight
times less effective in inducing lethal GVHD than the same dose ofCD4' cells from
J
Q
>
Q 7
N
W
C7 Q F Z
W
U 2 W a
e
m
W
t7
F 2 W
U
w a
NORMAL CD4+ CELLS
TLI CD4+CELLS
FIGURE 4.
￿
Comparison ofGVHD mediated by
CD4' cells from normal and TLI-treated mice.
24 hafterlethal wholebody irradiation (850 rad;
p), each C57BL/Ka mouse received intrave-
nously 2.5 x 106 allogeneic BALB/c bone
marrow cells (/). Simultaneously, graded doses
ofCD4' spleen cells from normal BALB/c mice;
5 x 105(O), 106 (A), and2.5 x 106 (A)or from
TLI-treated BALB/c mice; 2.5 x 106 (A), 5 x
106(*), and 10' (O)were injected intravenously
into each host. The mortality rate was recorded
up to 100d afterthe cell transfer.Therewere six
mice in each group.BASS ET AL .
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normal mice. The markedly reduced capacity ofTLI CD4' cells to induce GVHD
was observed in three other experiments .
Effect ofAdding TLI CD4' Cells to Normal CD4' Cells in theGVHD Assay.
￿
To iden-
tify whether the reduced efficiency ofTLI CD4' cells in inducing GVHD was due
to suppressor cells that have been observed in the spleen afterTLI (37-39), an ex-
periment was done to test the ability of CD4' cells from TLI mice to suppress
normal GVHD. 2.5 x 106 TLI BALB/c CD4' cells were injected intravenously into
lethally irradiated C57BL/Ka mice in combination with 2.5 x 106 each of normal
BALB/c BM cells and CD4' cells . The mortality rate is shown in Fig . 5.
All mice that received irradiation without BM cells died within 2 wk. None of
the irradiated mice given allogeneicBM cells died within 100 d . One ofthe sixmice
receiving TLI CD4' cells died 64 d after cell transfer; in comparison, all mice given
the same number of normalCD4' cells survived <3 wk. When 2.5 x 106 TLICD4'
cellswere coinjected with normal CD4' cells, the TLI CD4' cells failed to suppress
the lethalGVHD. All six mice died rapidly after the two inoculaofCD4' cells were
coinjected . Thus, the high survival rate of mice injected with TLI CD4' cells was
more likely due to the lack ofGVHD-inducing cells rather than to the presence of
suppressor cells in the cell inoculum .
Comparison ofCytokine Secretion by NormalandTLISpleen Cells.
￿
Theresults described
above demonstrated that unfractionated or CD4' spleen cells from TLI-treated
mice had a relatively normal ability to help B cells in the adoptive antiTNP anti-
body response, but had an impaired capacity to transferDTH or to induceGVHD.
Since IL-4 and IL-5 are important cytokines in augmenting the antibody responses
ofB cells, and IL-2 and IFN-y are considered more crucial forthe function of cell-
mediated immunity, the levels of cytokine secretion of spleen cells from normal or
TLI-treated BALB/c mice were analyzed .
Spleen cells (10'/ml) obtained from both normal and TLI-treated BALB/c mice
(12 mice/group) were stimulated with either hamster anti-mouse T3 mAb or Con
A plus PMA in vitro. Supernatants were harvested after 8 and 24 h and assayed
for cytokine secretion.
Table II shows the levels of four cytokines from the spleen cell supernatants 24
h after stimulation . ConA plus PMA, in general, gavea much stronger stimulation
FIGURE 5 .
￿
Effect of adding CD4' spleen cells
obtained from TLI-treated mice to normal
CD4' cells in theGVHD assay. 24 h after lethal
irradiation (850 rad; *), each C57BL/Ka mouse
was injected intravenously with 2.5 x 106 allo-
geneic BALB/c bone marrow cells (O)and 2.5 x
106CD4' spleen cells from normal BALB/c mice
(A) or TLI-treated BALB/c mice (A) . Another
group of mice received 2.5 x 10 6 allogeneic
BALB/c bone marrow cells, 2.5 x 106 CD4*
spleen cells from normal BALB/c mice, and the
same number of CD4' spleen cells from TLI-
treated mice (p) . There were six mice in each
group.1504
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TABLE II
Profiles of Cytokine Production from Unfractionated Spleen Cells 24 h after Stimulation
107/ml unfractionated spleen cells were stimulated with either anti-T3 antibody (final con-
centration 1 :200) or Con A (5 ;+g/ml) plus PMA (10 ng/ml). The supernatants were harvest-
ed 24 h later. The levels of IL-2 or IL-4 were measured by colorimetric MTT bio-assays,
and the levels of IL-5 or IFN-.y were measured by ELISAs.
" There were 12 mice in each group. Data is represented by mean t SE.
than anti T3 antibody with both normal and TLI spleen cells, butthecytokine secretion
pattern was consistent in the two groups. TLI spleen cells secreted mean levels of
IL-5 at least as high as thoseof normal spleen cells, and 59-88% of themean normal
level of IL-4. The same cells only secreted 5-9% of the mean normal level of IL-2
and 6-20% of the mean normal level of IFN-y. No detectable cytokines were found
in the supernatants lacking antiT3 antibody or Con A plus PMA. The superna-
tants harvested at 8 h after stimulation showed a lower cytokine concentration, but
a similar pattern (data not shown).
Characterization ofAlloreactive Clonesfrom Spleen Cells ofNormal and TLI-treatedMice.
Alloantigen-specific clones from both normal andTLI mice were established by lim-
itingdilution. Theclones were stimulated with alternatecycles ofirradiated allogeneic
spleen cells followed by growth in a medium containing rIL-2. Some clones were
lost in the early cycles of stimulation. After four stimulations over a period of 2 mo,
most clones stabilized and secreted sufficient cytokines to be detected. Three cloning
experiments have been carried out from the spleen cells ofnormal andTLI-treated
mice.
10 clones obtained from normal BALB/c spleen cells in cloning experiment no. 1
were selected in a blind manner (Table III). The quantitative results in different
clones couldnotbe compared, because thecell numbers in each harvestedwell differed
at thetime ofthe assay. 8of the 10 clones hadclear cytokine secretion patterns char-
acteristic of either Thl (IL-2 and IFN-y detected without IL-4 and IL-5) or Th2
(IL-4 and IL-5 detected without IL-2 and IFN-y) clones . Clones 1 and 10 were con-
sidered mixedcytokine clones because they secreted cytokines characteristic of both
Thl and Th2 cells. The surface phenotypes of these clones are also shown in Table
III. 9 ofthe 10 clones had at least 72% cell lysis with anti-CD4 antibody and com-
plement. Clone numbers 7 and 8 had some degree (8.5 and 15 .9%) of cell lysis with
the anti-CD8 antibody.
Comparison ofThl vs. Th2 Clone Ratios in Spleen Cellsfrom Normal and TLIMice.
￿
A
summaryof threecloning experimentsis shown in TableIV. The cloningfrequency
forboth normal and TLI-treated BALB/c mice was essentially equivalent (0.42-1.15%
for normal BALB/c mice; 0.14-1.48% formice 1 mo afterTLI treatment;0.83-0.95%
for mice 3 mo after TLI treatment). A minority of clones secreted only one of the
BALB/c Control"
IL-2
U/ml
<1
IFN-.y
ng/ml
<0.2
IL-4
U/ml
<1
IL-5
ng/ml
<0.3
BALB/c + anti-T3 1,343 t 156 8.6 t 1 .2 26 t 5 21 .0 t 2.0
TLI + anti-T3 63 1 7 0.6 1 0.4 15 1 3 34.3 1 4.5
BALB/c + Con A/PMA 2,865 t 264 13.9 t 2 .6 55 t 6 29 .7 t 2.2
TLI + Con A/PMA 268 t 58 2.7 t 0.8 48 t 4 30.3 t 1 .9BASS ET AL.
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TABLE III
Examples of Cytokine Production from CD4 + Clones
10 clones obtained from normal BALB/c spleen cells were selected in a blind
manner.
' Surface phenotype of the clone was determined by cytotoxicity assay.
TABLE IV
Summary of Cloning Experiments
' Frequency (%) = 100 x (number ofpositive wells)/(number ofcells per well x
number of wells).
two cytokines ina subset: IL-2 or IFN-y forThl clones; IL-4 orIL-5 forTh2 clones.
These clones were still categorized as either Thl or Th2 in Tables IV and V, but
could be more appropriately considered as Thl- or Th2-like clones.
The ratios ofThl and Th2 clones in both normal and TLI-treated BALB/c mice
are shown in Table V. In 73 clones obtained from normal BALB/c mice, there were
more Thl than Th2 clones. However, in 113 clones established from the spleens of
TLImice 1 moafter irradiation, there were seventimes more Th2 than Thl clones.
In a similar experiment, there were 43 clones obtained from BALB/c mice 3 mo
after TLI treatment. Previous studies have shown a normalization ofthe MLR at
that time point (31). The ratio ofThl to Th2 clones was 1:1 in thelatter mice. Out
Exp. Cells/well
Positive
wells Frequency' Thl
Cytokine
Th2
pattern
Mixed
1 Normal 10 4 0.42
12 6 2
30 16 0.56
TLI 30 4 0.14 1 3 0
2 TLI 3 14 0.97
5 62 4
10 57 1 .48
3 Normal 3 9 0.78
21 15 17
10 44 1 .15
TLI 3 9 0.78
6 26 6
10 29 0.76
TLI (3 mo) 3 11 0.95
17 17 9
10 32 0.83
Clone IL-2 IFN--y IL-4 IL-5
CD4`
cells'
CD8'
cells
Clone
type
U/ml ng/ml U/ml ng/ml %
1 <1 .2 4.3 342 .1 13.1 41 .7 -4.2 Mixed
2 339.4 11 .4 <0.1 <0.3 85 .9 3.9 Thl
3 38.2 11 .4 <0.1 <0.3 77 .6 7.2 Thl
4 121 .5 14.9 <0.1 <0.3 92.5 -8,9 Thl
5 <1 .2 <0.2 770.2 27 .8 90.8 2.5 TO
6 <1 .2 <0.2 439.2 43 .1 72 .8 3.3 Th2
7 55.3 36.1 <0.1 <0.3 95 .7 15.9 Thl
8 <1 .2 <0.2 151 .2 7 .4 88.8 8.1 Th2
9 77.2 23 .2 <0.1 <0.3 84.1 -4.8 Thl
10 469.8 13 .1 <0.1 1 .1 94.3 -2.3 Mixed1506
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TABLE V
Comparison of Tb1/Th2 Ratio of Normal and TLI-treated BAALA Mice
of a total of 229 clones gathered in three experiments, 38 mixed cytokine clones
were observed.
Discussion
The present studydemonstrated afunctional dichotomy ofunfractionated spleen
cellsobtained from mice 4-6wkafter TLI. Thespleen cells transferred aweakDTH
reaction but a normal serum antiTNP antibody response in the same recipients.
To relate the results obtained from unfractionated spleen cells to changes in the
CD4+ subset, purified CD4+ cells were used to study helper function in the anti-
body response, and cell-mediated immunity (GVHD) in adoptive celltransfer systems.
The data showed that CD4+ cells from TLI-treated BALB/c mice were able to pro-
vide normal helper function for adoptive serum antiTNP antibody responses with
normal B cells. The same cells also amplified the IgE antiTNP-KLH antibody re-
sponse ofnormal B cells at least as well as CD4+ cells from normal BALB/c mice.
On the other hand, these CD4+ cells were seven to eight times less efficient than
normal CD4+ cells in inducing lethal GVHD in irradiated C57BL/Ka mice. This
result was notlikely to beexplained bythe existence ofsuppressor cells in the spleen
ofTLI mice, since coinjection ofTLI CD4+ spleen cells with normal CD4' spleen
cells did not alter the GVHD-inducing capacity of the latter cells.
Experiments using two different polyclonal T cell stimulators, anti-T3 antibody
and Con A plus PMA, further demonstrated that both IL-2 and IFN-'Y secretion
in vitro were profoundly depressed in spleen cells obtained from TLI-treated mice.
However, IL-4 and IL-5 secretion in vitrowere close to normal. Since the biological
activities ofcytokines in stimulated cell supernatants have been shown to correlate
fairly wellwith theirmRNAlevels (13), itis reasonableto expect thatsecretedcytokines
ofspleen cells from TLI mice could also reflect their level oftranscription activity.
The above studies indicated that spleen cells obtained from mice 4-6 wk after
TLI showed several characteristics that suggested a selective deficiency ofThl-like
cell functions. Thecells hadareducedabilityto adoptivelytransfer17TH andGVHD
(cell-mediated immunity), and synthesized reduced amounts ofIL-2 andIFN-y in
response topolyclonal stimulation. In contrast, theTh2-likefunctionsofTLI-derived
CD4+ cells were similar to those of normal BALB/c mice. B cell helper function
in an adoptive transfer system was normal, and the synthesis of IL-4 and IL-5 by
spleen cells from TLI-treated mice was close to normal values.
Since these results were consistent with selective depletion ofThl-like cells from
the spleen ofTLI-treated mice, we attempted to directly determine whether there
BALB/c TLI (1 mo) TLI (3 mo)
Positive wells 73 113 43
Thl 33 12 17
Th2 21 91 17
Thl/Th2 1:0.64 1:7.58 1 :1
Mixed cytokine clones 19 10 9BASS ET AL.
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was a selective deficiency of precursor cells ofThl clones after TLI. Spleen cells
from TLI and normal mice were stimulated in vitro with alloantigens, cloned by
limiting dilution, and their cytokine secretion patterns were analyzed to identify
Thl and Th2 clones. A total of229 clones were established from spleen cells from
both normal and TLI-treated BALB/c mice. Clones that secreted IL-2 or IFN-'y
without IL-4 and IL-5 can be considered Thl-like, and those that secreted IL-4 or
IL-5 without IL-2 and IFN-y can be considered Th2-like. Spleen cells from normal
BALB/c mice generated more Thl and Th2 clones (ratio 1:0.6). Spleen cells from
TLI-treated mice generatedatotal of 113 clones withmore Th2-than Thl-like clones,
thus inverting the Thl/Th2 ratio to ti1:7.6. Furthermore, 3 mo after TLI, a time
when the MLR recovers to normal levels (31), the ratio of Thl- to Th2-like clones
(1:1) was closer to that of normal mice.
The resultswith TLI mice can be explained by aselectivedecrease in thenumber
ofprecursor or mature Thl as compared with Th2-like cells in the spleen 4-6 wk
after TLI. Since most of the evidence showing normal Th2 but reduced Thl-like
cell numbers and function was derived from cloning or adoptive transfer experi-
ments, which would allowtime for differentiation ofprecursor cells, it is likely that
the differencesobserved in the TLI spleen are due to changes in the frequencies
ofThl-like precursorcells. This deficiency maybe duetoan inabilityofthe thymus
ofTLI-treated mice toproduceor export T cells capable ofdifferentiatinginto Thl-
like cells. Alternatively, the export of such cells may be normal, but post-thymus
maturation of Thl-like cells may be selectively impaired.
It is ofinterest that all Thl-like functions were reduced after TLI, but Th2-like
functions remained at normal levels, with the exception ofIgE secretion, which was
somewhat elevated. This may be related to the ability of IFN-y (from Thl cells)
to inhibitIL-4-induced IgE secretion, and therelease ofthisinhibition inTLI mice.
Two lines ofevidence suggest that there are other Th cell cytokine secretion pat-
terns in addition to the prototypical Thl and Th2 patterns. First, the Pgp-1' subset
ofCD4' spleen cells secretes substantial levels ofIL-2 but verylittle IFN-'r (40, 41),
and normal spleen cell populationsoften secrete IL-2 but little orno detectable IL-4
or IL-5 (42, 43). These results are not consistent with the pattern expected ifCD4+
spleen cell populations consisted only ofprototypic Thl and Th2 cells. Further evi-
dence for additional heterogeneity of Th cells was obtained in the present study,
since there were 38 mixed cytokine clones in a total of 229 clones analyzed in the
above experiments. This could be accounted for by multiple clones (Thl and Th2)
coexisting in a single well. However, it was unlikely that these wells contained mul-
tiple clones because of the low frequency of positive wells. Many clones of mixed
cytokine secretion phenotype have also been isolated in additional studies (Street,
N., and T. Mosmann, unpublished results), and in some cases, the mixed pattern
has remained stable on subcloning. These mixed cytokine clones might constitute
another type of CD4+ cells that combines the cytokine secretion and functions of
both Thl and Th2 cells. They may also represent different stages ofthe CD4+ cell
differentiationpathway. Regardless oftheextent ofheterogeneitywithin the Th popu-
lation, the present study shows that several immune functions are selectively and
coordinately reduced in TLI mice, and all ofthese correspond to functions of in
vitro Thl-like clones. Conversely, all functions predicted to be mediated by Th2-like
cells arepreserved. Thus, this study demonstrates adichotomy ofimmune function1508
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in vivo that parallels the dichotomy of immune functions mediated by Thl and Th2
clones in vitro.
Theprevious studies ofTLImice showed adiminished primary antibody response,
but a vigorous secondary antibody response to SRBC (44). The primary antibody
response to DNP-KLH in CFA was also decreased (45). The current study shows
anormal ability of TLI spleen cells to adoptively transfer the primary antibody re-
sponse to TNP-KLH in aqueoussolution, and appearsinconsistent with the previous
results. However, differences in activation of Thl- or Th2-like cells might be deter-
mined by the type of antigen or adjuvant used. In recent cloning experiments, it
wasfound that some antigens appear to preferentially favorthe activation and growth
of certain clones. Forexample, CFA injected into mice favors theactivation/differenti-
ation ofThl cells (Street, N., and T. Mosmann, unpublished results). Thus, in mice
given TLI, antibody responses that depend heavily on Thl-like cells might be sub-
stantially reduced.
Severalprevious studies from patients givenTLI support thecurrent conclusions.
Patients with Hodgkin's diseaselost their17TH skin reaction to dinitro-chlorobenzene
for many months after radiation therapy (30). In addition, purified CD4+ cells from
TLI-treated patients had markedly reduced proliferative responses to alloantigens
and mitogens in vitro (29). However, the CD4+ cells can help the same patients'
unirradiated B cells to produce normal levels of Ig in vitro in response to PWM
(Field, E., and S. Strober, unpublished observations) . The incidence of severe bac-
terial infection amongTLI patients was<1% (31). In addition, there are no significant
changesin totalor specific IgElevels in patients afterTLI (46). Thus, the dichotomy
of Th functional deficits observed in mice is consistent with the results in humans.
Summary
Purified CD4+ BALB/c spleen T cells obtained 4-6 wk after total lymphoid ir-
radiation (TLI) helped normal syngeneic B cells to produce a vigorous antibody
response to TNP keyhole limpet hemocyanin in adoptive cell transfer experiments.
However, the same cells failed to transfer delayed-type hypersensitivity to the adop-
tive hosts as measured by a foot pad swelling assay. In addition, purified CD4' cells
from TLI-treated mice were unable to induce graftvs. host disease in lethally irradi-
ated allogeneic C57BL/Ka recipient mice. In response to mitogen stimulation, un-
fractionated spleen cells obtained from TLI mice secreted normal levels of IL-4 and
IL-5, but markedly reduced levels of IL-2 and INFy. A total of 229 CD4' clones
from spleen cells of both normal and TLI-treated mice were established, and the
cytokine secretion pattern from each clone was analyzed. The results demonstrate
that the ratio of Thl- and Th2-like clones in the spleens of normal BALB/c mice
is 1:0.6, whereas the ratio in TLI mice is ti 1:7 .
These results suggest that Th2-like cells recover rapidly (at N4-6 wk) after TLI
treatment and account for the early return of antibody helper activity and secretion
of IL-4 and IL-5, but Thl-like cells recover more slowly (in -3 mo) after irradia-
tion, and this accounts for the deficit in cell-mediated immunity and the reduced
amount of IL-2 and IFN-y secretion.
We thank Robert Coffmanfor providingthe technique and reagents forIgE antibody deter-
mination, and Sussan Jones for operating the FACS.
Receivedfor publication 2 May 1989 and in revisedform 17fuly 1989.BASS ET AL.
￿
1509
References
1 . Janeway, C. A.,Jr., S. Carding, B. Jones,J. Murray, P Portoles, R. Rasmussen, J. Rojo,
K. Saizawa, J. West, and K. Bottomly, 1988. CD4' T cells: specificity and function. Im-
munol. Rev. 101:39.
2 . Doyle, C., andJ. L. Strominger. 1987. Interaction between CD4 and class11 MHC mol-
ecules mediates cell adhesion. Nature (Loud.). 330:256.
3 . Swain, S. L. 1983. T cells subsets and the recognition of MHC class. Immunol Rev. 74:129.
4. Tada, T., T Takemori, K. Odumura, M. Nonada, and T Tokuhisa. 1978. Two distinct
types of helper T cells involved in the secondary antibody response: independent and
synergistic effects of Ia- and Ia' helper T cells. J. Exp. Med. 147:446.
5 . Swierkosz, J. E., P Marrack, and J. Kappler. 1979. Functional analysis of T cells ex-
pressing antigens. f. Exp. Med. 150:1293.
6. Waldman, H. 1977. Conditions determining the generation and expression of T helper
cells. Immunol Rev. 35:121.
7. Imperiale, M. J., D. A. Faherty J. F. Sproviero, and M. Zauderer. 1982. Functionally
distinct helper T cells enriched under different culture conditions cooperate with different
B cells. J. Immunol. 129:1843.
8. Melchers, I., K. Fey, and K. Eichmann. 1982. Quantitative studies on T cell diversity.
III. Limiting dilution analysis ofprecursor cells for T helper cells reactive to xenogeneic
erythrocytes. J. Exp. Med. 156:1587.
9. Kim,J., A. Woods, E. Becker-Dunn, and K. Bottomly. 1985. Distinct functional pheno-
types of cloned la-restricted helper T cells. J. Exp. Med. 162:188.
10. Silver, J., and B. Benacerraf. 1974. Dissociation of cell helper function and delayed hyper-
sensitivity. J. Immunol 113 :1872.
11 . Schreier, M. H., R. Tees, and A. A. Nordin. 1982. Establishment and characterization
of helper T cell clones: their functional heterogeneity and effect on the B cell responses
to particulate, soluble, and T-independent antigens. Lymphokine Res. 5:443.
12. Mosmann, T R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman.
1986. Two types ofmurine T cell clone. I. Definition according to profiles oflymphokine
activities and secreted proteins. ,J Immunol . 136:2348.
13. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two
types of mouse helper T cell clone. III. Further differences in lymphokine synthesis be-
tween Thl and Th2 clones revealed by RNA hybridization, functionally monospecific
bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
14. Cher, D. J., and T R. Mosmann. 1987. Two types of murine helper T cell clone. II.
Delayed-type hypersensitivity is mediated by Thl clones. ,J. Immunol. 138:3688.
15. Fong, T A. T, and T. R. Mosmann. 1989. The role ofINR,y in delayed-type hypersensi-
tivity mediated by Thl clones. J. Immunol. In press.
16. Tite,J. P, and C. A. Janeway, Jr. 1984. Cloned helper T cells can kill B lymphoma cells
in the presence ofspecific antigen: Ia restriction and cognate vs. noncognate interactions
in cytolysis. Eur. J. Immunol. 14:878 .
17. Mond, J. M., F D. Finkelman, C. Sarma, J. Ohara, and S. Serrate. 1985 . Recombinant
interferon--y inhibits the B cell proliferative response stimulated by soluble but not by
sepharose-bound anti-immunoglobulin antibody. ,I Immunol. 135:2513.
18. Coffman, R. L., andJ. Carty. 1986. A T cell activity that enhances polyclonal IgE produc-
tion and its inhibition by interferon-y. J. Immunol. 136:949.
19. Snapper, C. M., and W E. Paul. 1987. Interferon-y and B cell stimulatory-factor-I recipro-
cally regulate Ig isotype production. Science (Wash. DC). 263:44.
20. Coffman, R. L., R. W Seymour, D. A. Lehman, D. D. Hiraki, J. A. Christiansen, B.
Shrader, H. M. Cherwinski, H. F J. Savelkoul, F D. Finkelman, M. W Bond, and T. R.
Mosmann. 1988. The role of helper T cell products in mouse B cell differentiation and
isotype regulation. Immunol Rev. 102:5.151 0
￿
Thl AND Th2 CELLS AFTER TOTAL LYMPHOID IRRADIATION
21 . Murray, P. D., S. L. Swain, and M. F. Kagnoff. 1985. Regulation of the IgM and IgA
anti-dextran B1355 response: synergy between gamma interferon, BCGFII and interleu-
kin-2. J. Immunol. 135:4105.
22 . Snapper, C. M., F. D. Finkelman, and W. E. Paul. 1988. Regulation of IgG1 and IgE
production by interleukin-4. Immunol. Rev. 102:51 .
23 . Murray, P D., D. T. McKenzie, S. L. Swain, and M. F. Kagnoff. 1987. IL-5 and IL-4
produced by Peyer's patch T cells selectively enhance IgA expression.J. Immunol. 138:2669.
24. Vitetta, E. S., K. Brooks, Y. W. Chen, P. Isakson, S. Jones, P Layton, G. C. Mishra,
E. Pure, E. Weiss, C. Ward, D. Yuan, P. Tucker, J . W. Uhr, and P. H. Krammer. 1984.
T cell derived lymphokines that induce IgM and IgG secretion in activated murine B
cells. Immunol. Rev. 78:137 .
25. Coffman, R. L., J. Ohara, M. W. Bond, J . Carty, A. Zlotnik, and W. E. Paul. 1987.
B cell stimulatory factor I enhances the IgE response of lipopolysaccharide-activated B
cells. J. Immunol. 136:4538.
26. Finkelman, F. D., I. M. Katona, J. F. Urban, Jr., C. M. Snapper, J. Ohara, and W. E.
Paul. 1986. Suppression of in vivo polyclonal IgE responses by monoclonal antibody to
the lymphokine B cell stimulatory factor-1. Proc. Natl. Acad. Sci. USA. 83:9675 .
27 . Mosmann, T. R., and R. L. Coffman. 1987 . Two types of mouse helper T-cell clone.
Immunol. Today. 8:223.
28. Kaplan, H. S. 1980. Hodgkin's Disease. Second Ed. Harvard University Press, Cam-
bridge, MA. 366-441.
29. Field, E. H., E. G. Engleman, C. P. Terrell, and S. Strober. 1984. Reduced in vitro im-
mune responses of purified human Leu-3 (helper/inducer phenotype) cells after total
lymphoid irradiation. J. Immunol. 132:1031.
30. Fuks, Z., S. Strober, A. M. Bobrove, T. Sasazuki, A. McMichael, and H. S. Kaplan.
1976. Long-term effects of radiation on T and B lymphocytes in the peripheral blood
of patients with Hodgkin's disease. J. Clin. Invest. 58:803 .
31 . Strober, S., S. Slavin, M. Gottlieb, I. Zan-Bar, D. P King, R. T. Hoppe, Z. Fuks, F. C .
Grumet, and H. S. Kaplan. 1979. Allograft tolerance after total lymphoid irradiation
(TLI). Immunol. Rev. 46:87.
32 . Wysocki, L. J ., and V. L. Sato. 1978. "Panning" for lymphocytes: a method for cell selec-
tion. Proc. Nad. Acad. Sci. USA. 75 :337.
33 . Little, B. R., and H. N. Eisen. 1967 . Preparation ofimmunogenic 2,4-dinitrophenyl and
2,4,6-trinitrophenyl proteins. Methods Immunol. Immunochem. 1:128.
34. Schurs, A. H. W. M., and B. K. Van Weeman. 1977. Enzyme immunoassay. Clin. Chim.
Acta. 81:1.
35 . Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: applica-
tion to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55 .
36. Schumacher, J. H., A. O'Garra, B. Schrader, A. van Kimmenade, M. W. Bond, T. R.
Mosmann, and R. L. Coffman. 1988. The characterization of four monoclonal antibodies
specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked im-
munosorbent assays. J. Immunol. 141 :1576.
37 . Oseroff, A., S. Okada, and S. Strober. 1984. Natural suppressor (NS) cells found in the
spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express
the null surface phenotype.f Immunol. 132:101.
38. Strober, S. 1984. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid
irradiation: exploring obscure relationships. Annu. Rev. Immunol. 2:219.
39. King, D. P., S. Strober, and H. S. Kaplan. 1981. Suppression of the mixed leukocyte
response and graft-vs-host disease by spleen cells following total lymphoid irradiation
(TLI). J. Immunol. 126:1140.
40. Budd, R. C., J .-C. Cerottini, C . Horvath, C. Bron, T. Pedrazzini, R. C. Howe, andBASS ET AL.
￿
151 1
H. R. MacDonald. 1987. Distinction of Virgin and Memory T lymphocytes. Stable ac-
quisition ofthe Pgp-1 glycoprotein concomitant with antigenic stimulation.j Immunol.
138:3120.
41 . Budd, R. C., J.-C. Cerottini, and H. R. MacDonald. 1987. Selectively increased produc-
tion of interferon by subsets of Lyt2` and L3T4* T cells identified by expression of
Pgp-1. ,j. Immunol. 138:3583 .
42. Swain, S. L., D. T McKenzie, R. W. Dutton, S. L. Tonkonogy, and M. English. 1988.
The role ofIL-4 and IL-5: characterization of a distinct helper T cell subset that makes
IL-4 and IL-5 (Th2) and requires priming before induction of lymphokine secretion.
Immunol. Rev. 102:76.
43 . Swain, S. L., D. T McKenzie, A. D. Weinberg, and W. Hancock. 1988. Characteriza-
tion ofT helper 1 and 2 cell subsets in normal mice. Helper T cellsresponsible for IL-4
and IL-5 production are present as precursors that require priming before they develop
into lymphokine-secreting cells. J. Immunol. 141:3445.
44. Zan-Bar, I., S. Slavin, and S. Strober. 1979. Effect of total lymphoid irradiation (TLI)
on the primary and secondary antibody response to sheep red bloodcells. Cell. Immunol.
45:167.
45 . Tanay, A., and S. Strober. 1984. Opposite effects oftotal lymphoid irradiation on T cell-
dependent and T cell-independent antibody responses. ,j Immunol. 132:979.
46. Terr, A. I., R. B. Moss, and S. Strober. 1987. Effect of total lymphoid irradiation on
IgE antibody responses in rheumatoid arthritis and systemic lupus erythematosus. f.
Allergy Clin. Immunol. 80:798.